Cargando…
Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
Accumulation of amyloid-β peptide (Aβ) in the brain is closely associated with cognitive decline in Alzheimer's disease (AD). Stereotaxic infusion of neprilysin-encoding viral vectors into the hippocampus has been shown to decrease Aβ in AD-model mice, but more efficient and global delivery is...
Autores principales: | Iwata, Nobuhisa, Sekiguchi, Misaki, Hattori, Yoshino, Takahashi, Akane, Asai, Masashi, Ji, Bin, Higuchi, Makoto, Staufenbiel, Matthias, Muramatsu, Shin-ichi, Saido, Takaomi C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600598/ https://www.ncbi.nlm.nih.gov/pubmed/23503602 http://dx.doi.org/10.1038/srep01472 |
Ejemplares similares
-
Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010) -
Amyloid Beta Annular Protofibrils in Cell Processes and Synapses Accumulate with Aging and Alzheimer-Associated Genetic Modification
por: Kokubo, Hideko, et al.
Publicado: (2009) -
PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
por: Iwata, Nobuhisa, et al.
Publicado: (2016) -
Systemic Delivery of Tyrosine-Mutant AAV Vectors Results in Robust Transduction of Neurons in Adult Mice
por: Iida, Asako, et al.
Publicado: (2013) -
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
por: Ohmori, Tsukasa, et al.
Publicado: (2017)